PKM and retinal degeneration: While the ability of these novel, more soluble PKM2 activators to improve photoreceptor survival in pre-clinical models of retinal degeneration needs to be ascertained in future studies, the work herein provides the basis for new therapeutic agents that could impact millions of patients by combating currently untreatable retinal degenerative diseases.